Predicting costs of care in heart failure patients

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Smith, David H ^a   Johnson, Eric S ^a   Blough, David K ^c   Thorp, Micah L ^a,b   Yang, Xiuhai ^a   Petrik, Amanda F ^a   Crispell, Kathy A ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b University of Washington ^*  (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COST OF ILLNESS; ECONOMICS; FEMALE; HEALTH CARE COST; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICS; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NORTHWESTERN UNITED STATES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870180305     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-434     Document Type: Article

References (17)

1. Heart disease and stroke statistics-2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Rosamond W, Flegal K, Friday G, et al. Circulation 2007 115 69 e171 10.1161/CIRCULATIONAHA.106.179918 17194875 (Pubitemid 46226160)
2. The economic burden of chronic cardiovascular disease for major insurers. Trogdon JG, Finkelstein EA, Nwaise IA, Tangka FK, Orenstein D, Health Promot Pract 2007 8 234 242 10.1177/1524839907303794 17606951
3. Economic burden of heart failure: a summary of recent literature. Lee WC, Chavez YE, Baker T, Luce BR, Heart & Lung: The Journal of Acute and Critical Care 2004 33 362 371 10.1016/j.hrtlng.2004.06.008 23251943 (Pubitemid 39592989)
4. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. McAlister FA, Stewart S, Ferrua S, McMurray JJ, J Am Coll Cardiol 2004 44 810 819 15312864 (Pubitemid 39099578)
5. Validation of the acute heart failure index. Hsieh M, Auble TE, Yealy DM, Ann Emerg Med 2008 51 37 44 10.1016/j.annemergmed.2007.07.026 18045736 (Pubitemid 350309463)
6. Comparison of four clinical prediction rules for estimating risk in heart failure. Auble TE, Hsieh M, McCausland JB, Yealy DM, Ann Emerg Med 2007 50 2 127 135 In Press, Corrected Proof 10.1016/j.annemergmed.2007.02.017 17449141 (Pubitemid 47069602)
7. Validation of prognostic models among patients with advanced heart failure. Frankel DS, Piette JD, Jessup M, Craig K, Pickering F, Goldberg LR, J Card Fail 2006 12 430 438 10.1016/j.cardfail.2006.03.010 16911909 (Pubitemid 46106979)
8. Evaluating medication effects outside of clinical trials: new-user designs. Ray WA, Am J Epidemiol 2003 158 915 920 10.1093/aje/kwg231 14585769 (Pubitemid 37323253)
9. Trends in heart failure incidence and survival in a community-based population. Roger VL, Weston SA, Redfield MM, et al. JAMA 2004 292 344 350 10.1001/jama.292.3.344 15265849 (Pubitemid 38944258)
10. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) study. Go AS, Yang J, Ackerson LM, et al. Circulation 2006 113 2713 2723 10.1161/CIRCULATIONAHA.105. 577577 16754803 (Pubitemid 43947989)
11. Adjusting health benefit contributions to reflect risks. Hornbrook M, Goodman MJ, Risk based contributions to private health insurance Greenwich: JAI Press Inc, Hornbrook M, 1991 41
12. Longitudinal analysis of censored medical cost data. Baser O, Gardiner JC, Bradley CJ, Yuce H, Given C, Health Econ 2006 15 513 525 10.1002/hec.1087 16389670
13. Exact interpretation of dummy variables in semilogarithmic equations. van Garderen KJ, Shah C, Econ J 2002 5 149 159
14. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. Pfeffer MA, Burdmann EA, Chen CY, et al. N Eng J Med 2009 361 21 2019 2032 NEJMoa0907845 10.1056/NEJMoa0907845
15. Lifetime costs of medical care after heart failure diagnosis. Dunlay SM, Shah ND, Shi Q, et al. Circ Cardiovasc Qual Outcomes 2011 4 68 75 10.1161/CIRCOUTCOMES.110.957225 21139091
16. Patient-level estimates of the cost of complications in diabetes in a managed-care population. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Wagner EH, PharmacoEconomics 1999 16 285 295 10.2165/00019053-199916030-00005 10558040 (Pubitemid 29434156)
17. Cost of heart failure in patients receiving beta-blockers and angiotensin-converting enzyme inhibitors. Weintraub WS, Kawabata H, Tran M, L'italien GJ, Chen RS, Clin Drug Investig 2004 24 255 264 10.2165/00044011- 200424050-00002 17503887 (Pubitemid 38680226)